STOCK TITAN

Fortrea to Participate in September Investor Conferences

Fortrea leadership will engage investors at three September 2026 healthcare conferences, including a webcast fireside chat at the Baird event.

(Neutral)
(Neutral)
Tags

Fortrea (FTRE) will participate in three investor conferences in September 2026, featuring CEO Anshul Thakral, CFO Jason Knoblauch and SVP of Investor Relations Tracy Krumme.

Management will join a fireside chat and hold 1x1 and group meetings at the Baird 2026 Global Healthcare Conference in New York on September 15, 2026, from 2:00–2:30 p.m. EDT, with a live webcast and replay available via Fortrea’s Investor Relations “Events” page. They will also conduct 1x1 and group meetings at the Deutsche Bank 2026 Healthcare Summit in New York on September 16, 2026, and at the virtual RBC Pharma Services and Life Science Tools Conference on September 22, 2026. Investors seeking meetings are directed to contact their banking representatives.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Terms

cro, clinical pharmacology
2 terms
cro technical
"global contract research organization (“CRO”), today announced"
CRO stands for Contract Research Organization, a company that helps pharmaceutical and biotech firms manage and carry out clinical trials to test new medicines. For investors, CROs are important because they enable drug companies to develop new treatments more efficiently, potentially accelerating the path to market and affecting the company's growth prospects and success.
clinical pharmacology medical
"Fortrea provides phase I-IV clinical trial management, clinical pharmacology"
Clinical pharmacology is the study of how medicines behave in humans — how they are absorbed, distributed, metabolized and eliminated, and what effects and side effects they produce at different doses. For investors, it matters because these studies determine safe and effective dosing, identify risks, shape clinical trial outcomes and regulatory decisions, and therefore influence a drug’s chances of approval, market size and commercial value; think of it as the science that maps a drug’s real-world performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations, Tracy Krumme will participate in the following conferences in September:

Baird 2026 Global Healthcare Conference (NYC)

Date: Tuesday, September 15, 2026
Format: Fireside Chat & 1x1 and Group Meetings
Time: 2:00 -2:30 PM EDT
Webcast: FTRE Baird Webcast

Deutsche Bank 2026 Healthcare Summit (NYC)

Date: Wednesday, September 16, 2026
Format: 1x1 and Group Meetings

RBC Pharma Services and Life Science Tools Virtual Conference

Date: Tuesday, September 22, 2026
Format: 1x1 and Group Meetings

The live webcast and replay of the Baird fireside chat will be accessible through the “Events” section of Fortrea’s Investor Relations website. Investors interested in meeting with management should contact their banking representatives.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedInX and Bluesky.

Fortrea Contacts

Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com


FAQ

How can investors access the Fortrea fireside chat at the Baird 2026 Global Healthcare Conference?

The live webcast and replay of Fortrea’s fireside chat at the Baird 2026 Global Healthcare Conference will be available through the “Events” section of the company’s Investor Relations website.

How can investors request 1x1 or group meetings with Fortrea management at these conferences?

Investors who are interested in meeting with Fortrea’s management at the Baird, Deutsche Bank or RBC conferences are instructed to contact their banking representatives.

Keep reading